IFNL2 and neoplasm: Lasfar et al (2006) however, failed to elicit protective immunity against IFN-λ2-producing melanoma, although the IFN-λ2-secreting melanoma cells were rejected. These studies collectively suggest that IFN-λ can achieve anti-tumour effects through multiple mechanisms depending on a tumour model used.